| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXPE | Common Stock | Sale | -$200 | -1 | 0% | $199.77 | 159K | Mar 3, 2025 | Direct | F1 |
| transaction | EXPE | Common Stock | Sale | -$120K | -616 | -0.39% | $195.03 | 158K | Mar 3, 2025 | Direct | F1, F2 |
| transaction | EXPE | Common Stock | Sale | -$155K | -800 | -0.51% | $193.74 | 157K | Mar 3, 2025 | Direct | F1, F3 |
| transaction | EXPE | Common Stock | Sale | -$239K | -1.2K | -0.76% | $199.21 | 156K | Mar 3, 2025 | Direct | F1, F4 |
| transaction | EXPE | Common Stock | Sale | -$337K | -1.7K | -1.09% | $198.02 | 154K | Mar 3, 2025 | Direct | F1, F5 |
| transaction | EXPE | Common Stock | Sale | -$342K | -1.74K | -1.13% | $196.32 | 152K | Mar 3, 2025 | Direct | F1, F6 |
| transaction | EXPE | Common Stock | Sale | -$355K | -1.84K | -1.21% | $193.17 | 151K | Mar 3, 2025 | Direct | F1, F7 |
| transaction | EXPE | Common Stock | Sale | -$414K | -2.1K | -1.39% | $197.15 | 149K | Mar 3, 2025 | Direct | F1, F8 |
| holding | EXPE | Common Stock | 21.9K | Mar 3, 2025 | By Children's Trust | F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Khosrowshahi on May 22, 2023. |
| F2 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $194.59 to $195.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F3 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $193.51 to $194.45. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F4 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $198.76 to $199.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F5 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $197.62 to $198.52. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F6 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $195.62 to $196.61. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F7 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $192.50 to $193.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F8 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $196.62 to $197.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F9 | The reporting person disclaims beneficial ownership of these shares. |